Fig. 3 | International Journal of Obesity

Fig. 3

From: Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study

Fig. 3

a Changes in total cholesterol (mmol/L) in hypogonadal men with normal weight (left), overweight (middle) or obesity (right) treated with or without testosterone therapy. b Changes in HDL (mmol/L) in hypogonadal men with normal weight (left), overweight (middle) or obesity (right) treated with or without testosterone therapy. c Changes in LDL (mmol/L) in hypogonadal men with normal weight (left), overweight (middle) or obesity (right) treated with or without testosterone therapy. d Changes in triglycerides (mmol/L) in hypogonadal men with normal weight (left), overweight (middle) or obesity (right) treated with or without testosterone therapy. e Changes in Non-HDL cholesterol (mmol/L) in hypogonadal men with normal weight (left), overweight (middle) or obesity (right) treated with or without testosterone therapy. f Changes in remnant cholesterol (mmol/L) in hypogonadal men with normal weight (left), overweight (middle) or obesity (right) treated with or without testosterone therapy. Data are shown as least squares means ± standard errors. Shaded areas represent 95% confidence intervals. P values indicate statistical significance between groups for each year.

Back to article page